{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T08:54:27Z","timestamp":1714640067151},"reference-count":39,"publisher":"Japanese Society of Toxicology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2021]]},"DOI":"10.2131\/jts.46.515","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T22:13:16Z","timestamp":1635718396000},"page":"515-523","source":"Crossref","is-referenced-by-count":2,"title":["Altered expression of genes identified in rats with prostatic chronic inflammation in a prostate spheroid model treated by estradiol\/testosterone"],"prefix":"10.2131","volume":"46","author":[{"given":"Noriko","family":"Nakamura","sequence":"first","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Sloper","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Cho, S.W., Kim, Y.A., Sun, H.J., Kim, Y.A., Oh, B.C., Yi, K.H., Park, D.J. and Park, Y.J. (2016): CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma. Endocr. Relat. Cancer, <b>23<\/b>, 113-124.","DOI":"10.1530\/ERC-15-0196"},{"key":"2","doi-asserted-by":"crossref","unstructured":"De Nunzio, C., Presicce, F. and Tubaro, A. (2016): Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat. Rev. Urol., <b>13<\/b>, 613-626.","DOI":"10.1038\/nrurol.2016.168"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Friedrich, J., Seidel, C., Ebner, R. and Kunz-Schughart, L.A. (2009): Spheroid-based drug screen: considerations and practical approach. Nat. Protoc., <b>4<\/b>, 309-324.","DOI":"10.1038\/nprot.2008.226"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fontana, F., Raimondi, M., Marzagalli, M., Sommariva, M., Gagliano, N. and Limonta, P. (2020): Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery. Int. J. Mol. Sci., <b>21<\/b>, 6806.","DOI":"10.3390\/ijms21186806"},{"key":"5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pros.21081","author":"K. Fujita","year":"2010","unstructured":"Fujita, K., Ewing, C.M., Getzenberg, R.H., Parsons, J.K., Isaacs, W.B. and Pavlovich, C.P. (2010): Monocyte chemotactic protein-1 (MCP-1\/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia. Prostate, <b>70<\/b>, 473-481.","journal-title":"The Prostate","ISSN":"http:\/\/id.crossref.org\/issn\/0270-4137","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gu, G., Yuan, J., Wills, M. and Kasper, S. (2007): Prostate cancer cells with stem cell characteristics reconstitute the original human tumor <i>in vivo.<\/i> Cancer Res., <b>67<\/b>, 4807-4815.","DOI":"10.1158\/0008-5472.CAN-06-4608"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Guo, L., Wang, R., Zhang, K., Yuan, J., Wang, J., Wang, X., Ma, J. and Wu, C. (2019): A PINCH-1-Smurf1 signaling axis mediates mechano-regulation of BMPR2 and stem cell differentiation. J. Cell Biol., <b>218<\/b>, 3773-3794.","DOI":"10.1083\/jcb.201902022"},{"key":"8","doi-asserted-by":"crossref","unstructured":"H\u00e4rm\u00e4, V., Virtanen, J., M\u00e4kel\u00e4, R., Happonen, A., Mpindi, J.P., Knuuttila, M., Kohonen, P., L\u00f6tj\u00f6nen, J., Kallioniemi, O. and Nees, M. (2010): A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One, <b>5<\/b>, e10431.","DOI":"10.1371\/journal.pone.0010431"},{"key":"9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1097-0045(19991101)41:3<154::AID-PROS2>3.0.CO;2-M","author":"T.E. Hedlund","year":"1999","unstructured":"Hedlund, T.E., Duke, R.C. and Miller, G.J. (1999): Three-dimensional spheroid cultures of human prostate cancer cell lines. Prostate, <b>41<\/b>, 154-165.","journal-title":"The Prostate","ISSN":"http:\/\/id.crossref.org\/issn\/0270-4137","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hu, W.Y., Shi, G.B., Lam, H.M., Hu, D.P., Ho, S.M., Madueke, I.C., Kajdacsy-Balla, A. and Prins, G.S. (2011): Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology, <b>152<\/b>, 2150-2163.","DOI":"10.1210\/en.2010-1377"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hu, W.Y., Hu, D.P., Xie, L., Li, Y., Majumdar, S., Nonn, L., Hu, H., Shioda, T. and Prins, G.S. (2017): Isolation and functional interrogation of adult human prostate epithelial stem cells at single cell resolution. Stem Cell Res. (Amst.), <b>23<\/b>, 1-12.","DOI":"10.1016\/j.scr.2017.06.009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hochberg, Y. (1988): A sharper Bonferroni procedure for multiple tests of significance. Biomtrika, <b>75<\/b>, 800-802.","DOI":"10.1093\/biomet\/75.4.800"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Jeter, C.R., Liu, B., Liu, X., Chen, X., Liu, C., Calhoun-Davis, T., Repass, J., Zaehres, H., Shen, J.J. and Tang, D.G. (2011): NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene, <b>30<\/b>, 3833-3845.","DOI":"10.1038\/onc.2011.114"},{"key":"14","unstructured":"Kapa\u0142czy\u0144ska, M., Kolenda, T., Przyby\u0142a, W., Zaj\u0105czkowska, M., Teresiak, A., Filas, V., Ibbs, M., Bli\u017aniak, R., \u0141uczewski, \u0141. and Lamperska, K. (2018): 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch. Med. Sci., <b>14<\/b>, 910-919."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Katt, M.E., Placone, A.L., Wong, A.D., Xu, Z.S. and Searson, P.C. (2016): In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Front. Bioeng. Biotechnol., <b>4<\/b>, 12.","DOI":"10.3389\/fbioe.2016.00012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kaufman, J.M. and Vermeulen, A. (2005): The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev., <b>26<\/b>, 833-876.","DOI":"10.1210\/er.2004-0013"},{"key":"17","unstructured":"Kwon, O.J. and Xin, L. (2014): Prostate epithelial stem and progenitor cells. Am. J. Clin. Exp. Urol., <b>2<\/b>, 209-218."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Langhans, S.A. (2018): Three-Dimensional <i>in Vitro<\/i> Cell Culture Models in Drug Discovery and Drug Repositioning. Front. Pharmacol., <b>9<\/b>, 6.","DOI":"10.3389\/fphar.2018.00006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lazennec, G. and Richmond, A. (2010): Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med., <b>16<\/b>, 133-144.","DOI":"10.1016\/j.molmed.2010.01.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Li, Z. and Cui, Z. (2014): Three-dimensional perfused cell culture. Biotechnol. Adv., <b>32<\/b>, 243-254.","DOI":"10.1016\/j.biotechadv.2013.10.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Livak, K.J. and Schmittgen, T.D. (2001): Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method. Methods, <b>25<\/b>, 402-408.","DOI":"10.1006\/meth.2001.1262"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Mittler, F., Obe\u00efd, P., Rulina, A.V., Haguet, V., Gidrol, X. and Balakirev, M.Y. (2017): High-Content Monitoring of Drug Effects in a 3D Spheroid Model. Front. Oncol., <b>7<\/b>, 293.","DOI":"10.3389\/fonc.2017.00293"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nakamura, N., Davis, K., Yan, J., Sloper, D.T. and Chen, T. (2020a): Increased estrogen levels altered microRNA expression in prostate and plasma of rats dosed with sex hormones. Andrology, <b>8<\/b>, 1360-1374.","DOI":"10.1111\/andr.12780"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Nakamura, N., Vijay, V. and Sloper, D.T. (2020b): Gene expression profiling in dorsolateral prostates of prepubertal and adult Sprague-Dawley rats dosed with estradiol benzoate, estradiol, and testosterone. J. Toxicol. Sci., <b>45<\/b>, 435-447.","DOI":"10.2131\/jts.45.435"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Pampaloni, F. and Stelzer, E. (2010): Three-dimensional cell cultures in toxicology. Biotechnol. Genet. Eng. Rev., <b>26<\/b>, 117-138.","DOI":"10.5661\/bger-26-117"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Paczkowski, M., Kretzschmar, W.W., Markelc, B., Liu, S.K., Kunz-Schughart, L.A., Harris, A.L., Partridge, M., Byrne, H.M. and Kannan, P. (2021): Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer. Commun. Biol., <b>4<\/b>, 6.","DOI":"10.1038\/s42003-020-01529-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Prins, G.S. (2008): Endocrine disruptors and prostate cancer risk. Endocr. Relat. Cancer, <b>15<\/b>, 649-656.","DOI":"10.1677\/ERC-08-0043"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Prins, G.S., Hu, W.Y., Shi, G.B., Hu, D.P., Majumdar, S., Li, G., Huang, K., Nelles, J.L., Ho, S.M., Walker, C.L., Kajdacsy-Balla, A. and van Breemen, R.B. (2014): Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases <i>in vivo<\/i> carcinogenesis in human prostate epithelium. Endocrinology, <b>155<\/b>, 805-817.","DOI":"10.1210\/en.2013-1955"},{"key":"29","unstructured":"Rasband, W.S. (1997-2018): ImageJ. U. S. National Institutes of Health, Bethesda, Maryland, USA, https:\/\/imagej.nih.gov\/ij\/."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Russell, P.J. and Voeks, D.J. (2003): Animal models of prostate cancer. Methods Mol. Med., <b>81<\/b>, 89-112.","DOI":"10.1385\/1-59259-372-0:89"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Rycaj, K. and Tang, D.G. (2017): Molecular determinants of prostate cancer metastasis. Oncotarget, <b>8<\/b>, 88211-88231.","DOI":"10.18632\/oncotarget.21085"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Shaffer, J.P. (1995): Multiple hypothesis testing. Annu. Rev. Psychol., <b>46<\/b>, 561-584.","DOI":"10.1146\/annurev.ps.46.020195.003021"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Song, W. and Khera, M. (2014): Physiological normal levels of androgen inhibit proliferation of prostate cancer cells <i>in vitro.<\/i> Asian J. Androl., <b>16<\/b>, 864-868.","DOI":"10.4103\/1008-682X.129132"},{"key":"34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","author":"K. Takahashi","year":"2007","unstructured":"Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007): Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, <b>131<\/b>, 861-872.","journal-title":"Cell","ISSN":"http:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A.X., Wu, X., Ye, W., Chen, S., Zhou, W., Yu, Y., Wang, Y.Z., Ren, X., Li, H., Scherle, P., Kuroki, Y. and Wang, S.E. (2012): CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res., <b>72<\/b>, 2768-2779.","DOI":"10.1158\/0008-5472.CAN-11-3567"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Thoms, S., Ali, A.I., Jonczyk, R., Scheper, T. and Blume, C. (2018): Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids - Toxicity testing in a 3D cell culture approach. Toxicol. In Vitro, <b>53<\/b>, 10-19.","DOI":"10.1016\/j.tiv.2018.07.017"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Yao, S., Till, C., Kristal, A.R., Goodman, P.J., Hsing, A.W., Tangen, C.M., Platz, E.A., Stanczyk, F.Z., Reichardt, J.K., Tang, L., Neuhouser, M.L., Santella, R.M., Figg, W.D., Price, D.K., Parnes, H.L., Lippman, S.M., Thompson, I.M., Ambrosone, C.B. and Hoque, A. (2011): Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control, <b>22<\/b>, 1121-1131.","DOI":"10.1007\/s10552-011-9787-7"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Zink, D., Chuah, J.K. and Ying, J.Y. (2020): Assessing Toxicity with Human Cell-Based In Vitro Methods. Trends Mol. Med., <b>26<\/b>, 570-582.","DOI":"10.1016\/j.molmed.2020.01.008"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Zhao, H., Sun, N., Young, S.R., Nolley, R., Santos, J., Wu, J.C. and Peehl, D.M. (2013): Induced pluripotency of human prostatic epithelial cells. PLoS One, <b>8<\/b>, e64503.","DOI":"10.1371\/journal.pone.0064503"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/46\/11\/46_515\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T04:09:09Z","timestamp":1636171749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/46\/11\/46_515\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.46.515","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}